Prediction: Lilly Will Reach $1,200 in 2026 — Investment Thesis
Eli Lilly’s GLP-1 drugs are redefining growth in obesity and diabetes treatment. This article lays out why the stock ...
Uncover effective strategies to find cash for bills quickly. Ensure you have the funds needed to cover essential expenses.
24,104 articlesEli Lilly’s GLP-1 drugs are redefining growth in obesity and diabetes treatment. This article lays out why the stock ...
When a senior vice president sells stock, it can spark questions about a company's direction. This guide explains wha...
With SpaceX poised to hit the public markets, a wave of megadeals led by Elon Musk looms. Analysts warn the IPO could...
Two international small-cap funds, AVDV and DLS, offer different paths to income in a changing 2026 market. This divi...
Rivian is under renewed investor scrutiny as the R2 launch tests demand and governance structure limits shareholder i...
As quantum progress accelerates, investors look for tech stocks before Q-Day that blend growth with resilience. Here ...
As the quarter winds down, Monday’s best Wall Street calls set the tone, spotlighting tech, energy and consumer names...
Oracle stock is under pressure amid a tech-wide selloff, but a massive AI backlog could provide durable revenue and u...
As Medicare Part B costs climb in 2026, delaying enrollment can trigger lifelong penalties. Experts warn retirees to ...
MicroStrategy's crypto treasury, dubbed Strategy, remains substantially underwater as Saylor signals another bitcoin ...
Dell Technologies rides a surge in AI infrastructure demand, with a raised outlook and a growing AI backlog lifting t...
Market cycles swing, and a growth-driven Vanguard ETF could capture momentum in the second half of 2026. Here’s how t...